Medindia

X

Canine Painkiller unveiled by Novartis

by Medindia Content Team on  January 3, 2003 at 3:39 PM Drug News   - G J E 4
Canine Painkiller unveiled by Novartis
Novartis received approval from the Food and Drug Administration to begin marketing Deramaxx, a canine painkiller, which will be used to relieve post-operative pain in dogs. This drug being produced by a Novartis facility at Puerto Rico is the result of a development project undertaken by Novartis Animal Health that was run for several years at veterinary clinics, colleges and its manufacturing facilities.
Advertisement

The marketing campaign for the drug was launched in late September and veterinarian offices were the primary focus. Novartis expects to spend $25 million to market Deramaxx with a goal of reaching every veterinarian in the country in the first year. The company is banking on pet owner appeal to make this new drug a success.

Advertisement
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All